FABP2 (Protein|Antibody|cDNA Clone|ELISA Kit)

All FABP2 reagents are produced in house and quality controlled, including 2 FABP2 Antibody, 29 FABP2 Gene, 1 FABP2 Protein, 1 FABP2 qPCR. All FABP2 reagents are ready to use.

Recombinant FABP2 proteins are expressed by E. coli with fusion tags as C-His.

FABP2 antibodies are validated with different applications, which are ELISA, WB, ICC/IF, IF.

FABP2 cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each FABP2 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.

FABP2 Protein (1)


FABP2 Protein, Human, Recombinant (His Tag)


Expression host: E. coli

Human FABP2 / I-FABP Protein 8434

FABP2 Antibody (2)

Application Clonality

Anti-FABP2 Antibody


Specificity: Human

Application: ELISA

Clonality: PAb

Anti-FABP2 Antibody


Application: WB,ICC/IF,IF

Clonality: PAb

Mouse FABP2 Western blot (WB) 20899

FABP2 cDNA Clone (29)


FABP2 qPCR Primer (1)

Fatty acid binding protein (FABP) is one of the intracellular proteins, with a low molecular weight of approximately 15 kDa, that plays important roles in the transportation and metabolism of long-chain fatty acids. FABP family proteins could be used as tissue specific injury marker based on the following characteristics of FABP. The intestinal fatty acid binding protein (I-FABP), or fatty acid-binding protein 2 (FABP2), an intracellular protein expressed only in the intestine, involved in the absorption and intracellular transport of dietary long chain fatty acids. The FABP2 gene is proposed as a candidate gene for diabetes because the protein it codes is involved in fatty acid (FA) absorption and metabolism. Numerous studies have assessed FABP2 gene variants. A transition of G to A at codon 54 of FABP2 results in an amino acid substitution (Ala54 to Thr54), which is common in diverse populations and results in increased FA absorption in vivo. Some evidence indicates that this variant may be associated with type 2 diabetes. This polymorphism was associated with some cardiovascular risk factors. The cytosolic human intestinal fatty acid binding protein (hFABP2) is proposed to be involved in intestinal absorption of long-chain fatty acids. FABP2 may also help maintain energy homeostasis by functioning as a lipid sensor.